In both patients with the metabolic syndrome and type 2 diabetes, it has been suggested that enhanced visfatin/Nampt levels are associated with advanced carotid atherosclerosis, estimated as the intima-media thickness (IMT) in this artery [35, 38]. The gene discussed is NAMPT; the disease is type 2 diabetes mellitus.